Bexarotene in Treating Patients With Metastatic Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1998
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to study the effectiveness of bexarotene in treating patients who have metastatic breast cancer.
Epistemonikos ID: 5be43549d16d9cb1a1c3d3bc694cee65002ff01b
First added on: May 03, 2024